Welcome to Generic and Biosimilar Medicines of Southern Africa (GBMSA)
At Generic and Biosimilar Medicines of Southern Africa (GBMSA), we are dedicated to ensuring that Southern Africans has access to high-quality, affordable medicines. Our mission is to educate, advocate, and enhance the availability of generic and biosimilar medicines, empowering patients, healthcare professionals, and policymakers with trusted information.
WHO WE ARE
GBMSA was formerly known as the National Association of Pharmaceutical Manufacturers (NAPM). This term is no longer in use, as NAPM has transitioned into GBMSA, reflecting our evolving role in the pharmaceutical industry. As a leading industry association, we represent pharmaceutical manufacturers, both local and international, and importers advocating for the increased use of generic and biosimilar medicines to drive innovation and improve patient outcomes. Our work goes beyond medicine access—we actively contribute to economic growth, industry development, and healthcare transformation, ensuring a thriving, competitive pharmaceutical sector that benefits all South Africans.
Through collaboration and advocacy, GBMSA remains committed to improving affordability, accessibility, and innovation in healthcare, ensuring that life-saving medicines reach those who need them most.
OUR MISSION STATEMENT
To Champion access to quality and affordable medicines for people in Southern Africa, by supporting and promoting the sustainable growth of Generic and Biosimilar Medicines.
WHAT ARE GENERIC AND BIOSIMILAR MEDICINES?
Generic and biosimilar medicines provide the same therapeutic benefits as their brand-name counterparts but at a more affordable cost.
Generic Medicines
Generic medicines are safe, effective, and equivalent alternatives to brand-name drugs. They contain the same active ingredients, work in the same way, and meet strict regulatory standards but are available at a more affordable price.
Biosimilar Medicines
Biosimilars are highly similar to biologic medicines but developed after the original biologic’s patent expires. They offer the same therapeutic benefits, particularly for chronic conditions like cancer, diabetes, and autoimmune diseases, while significantly reducing treatment costs.
Both generic and biosimilar medicines play a vital role in making healthcare more affordable and accessible. By choosing generic and biosimilar medicines, patients gain affordable access to essential treatments, provide healthcare providers expanded treatment options, and reduce overall costs to healthcare systems while maintaining high standards of care.
WHO CAN BENEFIT FROM GENERIC AND BIOSIMILAR MEDICINES?
- Patients – Access safe, effective, and affordable treatments for a wide range of conditions.
- Healthcare Professionals – Provide cost-effective treatment plans without compromising quality.
- Pharmacies & Hospitals – Improve medication availability and expand access to life-saving drugs.
- Health Insurers & Medical Schemes – Reduce healthcare costs while ensuring patient adherence to treatment.
WHY CHOOSE GENERIC & BIOSIMILAR MEDICINES?
- Cost-Effective – Receive the same trusted treatment at a lower price.
- Scientifically Proven – Approved by regulatory authorities for safety, efficacy, and quality.
- Widely Available – Dispensed in pharmacies, hospitals, and healthcare facilities across South Africa.
- Sustainable Healthcare – Supports the long-term affordability of essential medicines.
HOW TO ACCESS GENERIC AND BIOSIMILAR MEDICINES
Obtaining these medicines is easy and accessible:
- Ask Your Doctor or Pharmacist – Request generic alternatives to prescribed medications.
- Check with Your Medical Scheme – Many insurers encourage the use of cost-saving generics.
- Visit Your Nearest Pharmacy – Widely stocked and available across South Africa.
If you’re a healthcare provider, explore our professional resources to support your patients in transitioning to safe and affordable treatment options.
ADDRESSING COMMON CONCERNS
Many patients and healthcare providers have questions about generic and biosimilar medicines. Below are some of the most common concerns and their solutions:
Are generics as effective as brand-name drugs?
Yes. Generic medicines are bioequivalent to their brand-name counterparts, meaning they provide the same therapeutic effect, safety, and quality.
Are biosimilars safe?
Absolutely. Biosimilars undergo rigorous regulatory testing to ensure they meet the same high standards of safety, efficacy, and quality as the original biologic medicines.
Why are generics cheaper?
Generics do not require expensive research and development costs, allowing them to be sold at lower prices while maintaining the same high quality.
How can I ensure I am getting a trusted generic or biosimilar?
Always consult with your doctor or pharmacist and look for regulatory approval from the South African Health Products Regulatory Authority (SAHPRA).
RESOURCES, POLICY & INDUSTRY INSIGHTS
Stay informed about policy updates, industry research, and expert insights on generic and biosimilar medicines:
- Latest Healthcare Policy Updates
- Industry News & Regulatory Developments
- The GBM Blog – Expert Insights & Trends
For professionals and stakeholders, explore regulatory frameworks, research reports, and healthcare strategies that are shaping the future of affordable medicine in South Africa.
Our Members
